TriLink Biotechnologies


TriLink BioTechnologies specializes in the synthesis and production of complex and highly-modified nucleic acids for research, diagnostics, pre-clinical therapeutic and pharmaceutical applications. Since 1996, TriLink has been developing and manufacturing custom oligonucleotides, mRNA transcripts, nucleotides, PCR & RT-PCR reagents, NGS library preparation kits, bioconjugation, custom chemistry, and other small molecules.


Sign Up for Event Updates

Get Involved At World Vaccine Congress Washington


To Sponsor Or Exhibit

Marc Rhys-Evans
+44 20 7827 5945




To Register

Tayyab Abbasi
+44 20 7092 1210




Press Relations

Karina Kusova
+44 20 7092 1071